Dela Cruz, Rena .
HRN: 28-56-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/24/2026
03/02/2026
IV
900mg
Q8
Sp 1 LTCS, Thickly MSAF
Checking Initial Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines